Table 5 IHC Molecular subtype and AR expression
From: Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma
IHC molecular subtype | AR expression | p-value | |
|---|---|---|---|
|  | Positive | Negative | p = 0.016 |
Luminal | 44a (77.2%) | 43b (51.2%) | |
HER2 | 5a (8.8%) | 12a (14.3%) | |
Non-basal TNBC | 5a (8.8%) | 14a (16.7%) | |
Basal TNBC | 3a (5.3%) | 15b (17.9%) | Â |